MENU
+Compare
DERM
Stock ticker: NASDAQ
AS OF
Sep 16, 02:46 PM (EDT)
Price
$7.20
Change
+$0.08 (+1.12%)
Capitalization
187.33M

DERM Journey Medical Corp Forecast, Technical & Fundamental Analysis

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions... Show more

Industry: #Biotechnology
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DERM with price predictions
Sep 15, 2025

DERM's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for DERM moved out of overbought territory on August 13, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 instances where the indicator moved out of the overbought zone. In of the 26 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 43 cases where DERM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DERM as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DERM turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at .

DERM moved below its 50-day moving average on September 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DERM crossed bearishly below the 50-day moving average on September 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DERM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DERM broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 138 cases where DERM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DERM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.737) is normal, around the industry mean (17.216). P/E Ratio (39.077) is within average values for comparable stocks, (74.405). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). DERM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.774) is also within normal values, averaging (46.810).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DERM is expected to report earnings to fall 89.06% to -1 cents per share on November 05

Journey Medical Corp DERM Stock Earnings Reports
Q3'25
Est.
$-0.02
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.27
Q3'24
Beat
by $0.05
The last earnings report on August 12 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 10.07K shares outstanding, the current market capitalization sits at 187.33M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9237 E Via de Ventura Boulevard
Phone
+1 480 434-6670
Employees
58
Web
https://www.journeymedicalcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILXF2.770.16
+6.28%
Silex Systems Ltd.
SRRPF5.25N/A
N/A
Shagrir Group Veh Svcs Ltd
MSTH0.01N/A
N/A
Mystic Holdings Inc.
WSPOF208.68-0.04
-0.02%
WSP Global Inc
TWODY13.22-0.29
-2.16%
Taylor Wimpey Plc

DERM and Stocks

Correlation & Price change

A.I.dvisor tells us that DERM and CHRS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DERM and CHRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
+0.14%
CHRS - DERM
27%
Poorly correlated
-1.55%
CRDL - DERM
23%
Poorly correlated
+0.93%
AQST - DERM
23%
Poorly correlated
+1.78%
DRMA - DERM
22%
Poorly correlated
+0.46%
PRGO - DERM
22%
Poorly correlated
-2.33%
More

Groups containing DERM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
+0.14%
Pharmaceuticals: Generic
industry (221 stocks)
2%
Poorly correlated
+0.18%